Astellas Culls Positions Ahead Of Big Expiry

Balancing time and money
ASTELLAS LOOKS TO BALANCE COSTS AND SPEED NEW DRUGS TO MARKET • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Japan

More from Focus On Asia